MoonLake Immunotherapeutics

MLTX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001821586

SEC filings (opens in a new tab)

In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 5 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding MoonLake Immunotherapeutics changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of MLTX: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	116	1	136	+21
Shares	63.4M	595.6K	59.9M	−2.93M (−4.7%)
Value	$3.43B	$32.3M	$2.34B	−$1.06B (−31.2%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (37)

Institutions that held MoonLake Immunotherapeutics at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to MLTX in Q1 2025
Institution	Shares	Value	% of portfolio
Nuveen, LLC	673,343	$26.3M	0.01%
Logos Global Management LP	350,000	$13.7M	2.43%
Millennium Management LLC	344,320	$13.5M	0.01%
Octagon Capital Advisors LP	296,000	$11.6M	2.51%
Vestal Point Capital, LP	200,000	$7.81M	0.56%
Franklin Resources Inc	191,500	$7.48M	0.00%
First Turn Management, LLC	179,196	$7.00M	1.41%
Catalio Capital Management, LP	114,616	$4.48M	1.11%
Moody Aldrich Partners LLC	55,245	$2.16M	0.45%
Nicholas Investment Partners, LP	46,933	$1.83M	0.19%
Rhenman & Partners Asset Management AB	45,000	$1.76M	0.20%
Two Sigma Investments, LP	35,638	$1.39M	0.00%
Superstring Capital Management LP	32,145	$1.26M	1.50%
Tudor Investment Corp Et Al	31,592	$1.23M	0.01%
Two Sigma Advisers, LP	25,400	$992.4K	0.00%
Cantor Fitzgerald, L. P.	25,000	$976.8K	0.04%
Cubist Systematic Strategies, LLC	24,819	$969.7K	0.01%
Zimmer Partners, LP	24,500	$957.2K	0.02%
Verition Fund Management LLC	24,317	$950.1K	0.01%
Squarepoint Ops LLC	16,942	$661.9K	0.00%
J. Goldman & Co LP	14,664	$572.9K	0.02%
Dark Forest Capital Management LP	9,510	$371.6K	0.02%
Caxton Associates LLP	8,880	$346.9K	0.01%
XTX Topco Ltd	8,495	$331.9K	0.02%
New York State Common Retirement Fund	6,992	$273.2K	0.00%
Glenmede Trust Co NA	6,690	$261.4K	0.00%
Legato Capital Management LLC	6,142	$240.0K	0.03%
Virtus Investment Advisers, Inc.	3,050	$119.2K	0.03%
Quarry LP	2,400	$93.8K	0.02%
Caitong International Asset Management Co., Ltd	147	$5.74K	0.00%
Tower Research Capital LLC (TRC)	146	$5.70K	0.00%
Wealth Preservation Advisors, LLC	120	$4.69K	0.00%
Aquatic Capital Management LLC	82	$3.20K	0.00%
Creative Financial Designs Inc	10	$391	0.00%
TD Private Client Wealth LLC	9	$352	0.00%
True Wealth Design, LLC	4	$157	0.00%
Lindbrook Capital, LLC	4	$156	0.00%

Sold out (16)

Institutions that held MoonLake Immunotherapeutics at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of MLTX in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
EcoR1 Capital, LLC	332,522	$18.0M
Adage Capital Partners GP, L.L.C.	155,000	$8.39M
Alyeska Investment Group, L.P.	100,000	$5.42M
Point72 Asset Management, L.P.	98,719	$5.35M
Parkman Healthcare Partners LLC	54,294	$2.94M
UBS Oconnor LLC	20,740	$1.12M
Caption Management, LLC	12,371	$669.9K
Cinctive Capital Management LP	10,576	$572.7K
Y-Intercept (Hong Kong) Ltd	9,229	$499.8K
Mariner, LLC	5,028	$272.3K
PEAK6 LLC	5,000	$270.8K
Parallax Volatility Advisers, L.P.	3,208	$173.7K
Virtus ETF Advisers LLC	1,322	$71.6K
Skopos Labs, Inc.	78	$4.22K
National Bank of Canada	2	$108
IFP Advisors, Inc	0	$54

Not filed for Q1 2025 yet (1)

Institutions that held MoonLake Immunotherapeutics at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MLTX in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	595,581	$32.3M